Sotera Health Company
$16.28
▲
0.61%
2026-04-21 09:23:02
soterahealth.com
NMS: SHC
Explore Sotera Health Company stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$4.63 B
Current Price
$16.28
52W High / Low
$19.85 / $10.17
Stock P/E
59.4
Book Value
$2.13
Dividend Yield
—
ROCE
12.01%
ROE
15.42%
Face Value
—
EPS
$0.27
Exp Qtr EPS
—
Sector
Healthcare
Industry
Diagnostics & Research
Employees
3,000
Beta
1.88
Debt / Equity
375.56
Current Ratio
2.46
Quick Ratio
2.24
Forward P/E
14.68
Price / Sales
3.76
Enterprise Value
$6.3 B
EV / EBITDA
11.38
EV / Revenue
5.41
Rating
Buy
Target Price
$20.75
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
Cons
- Leverage is relatively high.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | BillionToOne, Inc. | $86.97 | 489.81 | $3.65 B | — | 2.74% | 2.3% | $138.7 / $61.96 | $10.48 |
| 2. | Myriad Genetics, Inc. | $5.14 | — | $484.84 M | — | -11.84% | -23.51% | $8.59 / $3.76 | $3.94 |
| 3. | Twist Bioscience Corporation | $61.88 | — | $3.79 B | — | -24.75% | -16.79% | $62.09 / $23.3 | $7.44 |
| 4. | Danaher Corporation | $189.21 | 37.67 | $133.79 B | 0.82% | 6.12% | 7.05% | $242.8 / $180.03 | $74.32 |
| 5. | Waters Corporation | $332.95 | 30.93 | $32.76 B | — | 20.92% | 29.28% | $414.15 / $275.05 | $43.01 |
| 6. | Guardant Health, Inc. | $90.8 | — | $11.97 B | — | -25.56% | 348.42% | $120.74 / $36.36 | $-0.76 |
| 7. | GeneDx Holdings Corp. | $69.71 | — | $1.92 B | — | -3.15% | -7.6% | $170.87 / $55.17 | $10.54 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 303.44 M | 311.31 M | 294.34 M | 254.52 M | 290.2 M | — |
| Operating Profit | 105.38 M | 111.18 M | 88.43 M | 57.04 M | 87.15 M | — |
| Net Profit | 34.85 M | 48.4 M | 7.96 M | -13.26 M | 12.32 M | — |
| EPS in Rs | 0.12 | 0.17 | 0.03 | -0.05 | 0.04 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.16 B | 1.1 B | 1.05 B | 1 B |
| Operating Profit | 362.03 M | 297.63 M | 276.69 M | 248.35 M |
| Net Profit | 77.95 M | 44.4 M | 51.38 M | -233.57 M |
| EPS in Rs | 0.27 | 0.16 | 0.18 | -0.82 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 3.26 B | 3.07 B | 3.13 B | 3.12 B |
| Total Liabilities | 2.66 B | 2.67 B | 2.69 B | 2.77 B |
| Equity | 606.03 M | 404.91 M | 443.73 M | 350.24 M |
| Current Assets | 613.41 M | 526.04 M | 557.24 M | 645.01 M |
| Current Liabilities | 249.58 M | 191 M | 230.65 M | 791.57 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 287.19 M | 224.16 M | -147.73 M | 277.96 M |
| Investing CF | -135.14 M | -179 M | -214.91 M | -181.9 M |
| Financing CF | -100.53 M | -50.56 M | 265.96 M | 197.76 M |
| Free CF | 149.18 M | 45.09 M | -362.71 M | 95.58 M |
| Capex | -138.02 M | -179.07 M | -214.97 M | -182.38 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 4.88% | 4.54% | — | — |
| Earnings Growth % | -13.58% | 122% | — | — |
| Profit Margin % | 4.03% | 4.9% | -23.27% | — |
| Operating Margin % | 27.05% | 26.37% | 24.74% | — |
| Gross Margin % | 54.73% | 55% | 55.5% | — |
| EBITDA Margin % | 40.18% | 38.77% | -1.73% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.